{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:04:57Z","timestamp":1778767497657,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/eye.2015.161","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T06:07:32Z","timestamp":1440742052000},"page":"1613-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data"],"prefix":"10.1038","volume":"29","author":[{"given":"T","family":"Boodhna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L J","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D P","family":"Crabb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"issue":"5","key":"BFeye2015161_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","volume":"91","author":"A Heijl","year":"2012","unstructured":"Heijl A, Buchholz P, Norrgren G, Bengtsson B . Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol 2012; 91 (5): 406\u2013412.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"BFeye2015161_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0008-4182(06)80025-6","volume":"41","author":"BC Chauhan","year":"2006","unstructured":"Chauhan BC . Group CGS. Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses. Can J Ophthalmol 2006; 41 (5): 566\u2013575.","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"BFeye2015161_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archophthalmol.2011.72","volume":"129","author":"CGV De Moraes","year":"2011","unstructured":"De Moraes CGV, Juthani VJ, Liebmann JM, Teng CC, Tello C, Susanna R et al. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol 2011; 129 (5): 562\u2013568.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"BFeye2015161_CR4","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1167\/iovs.14-14643","volume":"55","author":"BC Chauhan","year":"2014","unstructured":"Chauhan BC, Malik R, Shuba LM, Rafuse PE, Nicolela MT, Artes PH . Rates of glaucomatous visual field change in a large clinical population. Invest Ophthalmol Vis Sci 2014; 55 (7): 4135\u20134143.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"BFeye2015161_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/eye.2013.196","volume":"27","author":"T Keenan","year":"2013","unstructured":"Keenan T, Johnston R, Donachie P, Sparrow J, Stratton I, Scanlon P . United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. Eye 2013; 27 (12): 1397\u20131404.","journal-title":"Eye"},{"issue":"5","key":"BFeye2015161_CR6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ophtha.2013.11.031","volume":"121","author":"A Tufail","year":"2014","unstructured":"Tufail A, Xing W, Johnston R, Akerele T, McKibbin M, Downey L et al. The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections. Ophthalmology 2014; 121 (5): 1092\u20131101.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye2015161_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/eye.2012.51","volume":"26","author":"J Sparrow","year":"2012","unstructured":"Sparrow J, Taylor H, Qureshi K, Smith R, Birnie K, Johnston R . The Cataract National Dataset electronic multi-centre audit of 55 567 operations: risk indicators for monocular visual acuity outcomes. Eye 2012; 26 (6): 821\u2013826.","journal-title":"Eye"},{"issue":"5","key":"BFeye2015161_CR8","doi-asserted-by":"publisher","first-page":"e006535","DOI":"10.1136\/bmjopen-2014-006535","volume":"5","author":"T Butt","year":"2015","unstructured":"Butt T, Lee A, Lee C, Tufail A, Xing W, Johnston RL et al. The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes. BMJ Open 2015; 5 (5): e006535.","journal-title":"BMJ Open"},{"issue":"2","key":"BFeye2015161_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/opo.12187","volume":"35","author":"T Boodhna","year":"2014","unstructured":"Boodhna T, Crabb DP . Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data. Ophthalmic Physiol Opt 2014; 35 (2): 225\u2013230.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"BFeye2015161_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1167\/iovs.13-13006","volume":"55","author":"LJ Saunders","year":"2014","unstructured":"Saunders LJ, Russell RA, Kirwan JF, McNaught AI, Crabb DP . Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime. Invest Ophthalmol Vis Sci 2014; 55 (1): 102\u2013109.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"BFeye2015161_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/bjo.86.5.551","volume":"86","author":"D Bateman","year":"2002","unstructured":"Bateman D, Clark R, Azuara-Blanco A, Bain M, Forrest J . The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002; 86 (5): 551\u2013554.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2015161_CR12","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/bjophthalmol-2012-301827","volume":"96","author":"LJ Saunders","year":"2012","unstructured":"Saunders LJ, Russell RA, Crabb DP . Practical landmarks for visual field disability in glaucoma. Br J Ophthalmol 2012; 96: 1185\u20131189.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2015161_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1755-3768.1989.tb04105.x","volume":"67","author":"JM Wild","year":"1989","unstructured":"Wild JM, Dengler-Harles M, Searle AET, O'Neill EC, Crews SJ . The influence of the learning effect on automated perimetry in patients with suspected glaucoma. Acta Ophthalmol (Copenh) 1989; 67: 537\u2013545.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"BFeye2015161_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archopht.1989.01070010083032","volume":"107","author":"A Heijl","year":"1989","unstructured":"Heijl A, Lindgren G, Olsson J . The effect of perimetric experience in normal subjects. Arch Ophthalmol 1989; 107 (1): 81\u201386.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"BFeye2015161_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/archopht.1996.01100130017003","volume":"114","author":"A Heijl","year":"1996","unstructured":"Heijl A, Bengtsson B . The effect of perimetric experience in patients with glaucoma. Arch Ophthalmol 1996; 114 (1): 19\u201322.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFeye2015161_CR16","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1136\/bjo.2009.164897","volume":"94","author":"N Jansonius","year":"2010","unstructured":"Jansonius N . On the accuracy of measuring rates of visual field change in glaucoma. Br J Ophthalmol 2010; 94 (10): 1404\u20131405.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2015161_CR17","volume-title":"Clinical Decisions in Glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp E, Parrish RI, Anderson DR . Clinical Decisions in Glaucoma. The CV Mosby: St Louis, MO, 1993."},{"key":"BFeye2015161_CR18","unstructured":"R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria, 2008."},{"issue":"9975","key":"BFeye2015161_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"DF Garway-Heath","year":"2014","unstructured":"Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 2014; 385 (9975): 1295\u20131304.","journal-title":"Lancet"},{"issue":"7","key":"BFeye2015161_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/bjo.2005.088666","volume":"90","author":"CG Owen","year":"2006","unstructured":"Owen CG, Carey I, De Wilde S, Whincup P, Wormald R, Cook D . The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003. Br J Ophthalmol 2006; 90 (7): 861\u2013868.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"BFeye2015161_CR21","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00125-008-0989-9","volume":"51","author":"R Sim\u00f3","year":"2008","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C . Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 2008; 51 (9): 1574\u20131580.","journal-title":"Diabetologia"},{"issue":"4","key":"BFeye2015161_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ajo.2013.12.018","volume":"157","author":"NM Holekamp","year":"2014","unstructured":"Holekamp NM, Liu Y, Yeh W-S, Chia Y, Kiss S, Almony A et al. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration. Am J Ophthalmol 2014; 157 (4): 825\u2013833 e1.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"BFeye2015161_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/archopht.126.8.1030","volume":"126","author":"BC Chauhan","year":"2008","unstructured":"Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE . Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 2008; 126 (8): 1030\u20131036.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"BFeye2015161_CR24","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","volume":"114","author":"MC Leske","year":"2007","unstructured":"Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z . Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007; 114 (11): 1965\u20131972.","journal-title":"Ophthalmology"},{"issue":"9","key":"BFeye2015161_CR25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","volume":"111","author":"K Nouri-Mahdavi","year":"2004","unstructured":"Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004; 111 (9): 1627\u20131635.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye2015161_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","volume":"131","author":"S Drance","year":"2001","unstructured":"Drance S, Anderson DR, Schulzer M Group CN-TGS. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001; 131 (6): 699\u2013708.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"BFeye2015161_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ophtha.2009.06.028","volume":"117","author":"TS Prata","year":"2010","unstructured":"Prata TS, De Moraes CG, Teng CC, Tello C, Ritch R, Liebmann JM . Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage. Ophthalmology 2010; 117 (1): 24\u201329.","journal-title":"Ophthalmology"},{"issue":"1","key":"BFeye2015161_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E . Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121 (1): 48\u201356.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"BFeye2015161_CR29","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/eye.2011.213","volume":"25","author":"C Wesselink","year":"2011","unstructured":"Wesselink C, Stoutenbeek R, Jansonius N . Incorporating life expectancy in glaucoma care. Eye 2011; 25 (12): 1575\u20131580.","journal-title":"Eye"},{"issue":"10","key":"BFeye2015161_CR30","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1167\/iovs.12-10428","volume":"53","author":"RA Russell","year":"2012","unstructured":"Russell RA, Crabb DP, Malik R, Garway-Heath DF . The relationship between variability and sensitivity in large-scale longitudinal visual field data. Invest Ophthalmol Vis Sci 2012; 53 (10): 5985\u20135990.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"BFeye2015161_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/bjophthalmol-2012-302903","volume":"97","author":"SS Fung","year":"2013","unstructured":"Fung SS, Lemer C, Russell RA, Malik R, Crabb DP . Are practical recommendations practiced? A national multi-centre cross-sectional study on frequency of visual field testing in glaucoma. Br J Ophthalmol 2013; 97 (7): 843\u2013847.","journal-title":"Br J Ophthalmol"},{"issue":"27","key":"BFeye2015161_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3310\/hsdr02270","volume":"2","author":"D Crabb","year":"2014","unstructured":"Crabb D, Russell R, Malik R, Anand N, Baker H, Boodhna T et al. Frequency of visual field testing when monitoring patients newly diagnosed with glaucoma: mixed methods and modelling. Health Serv Deliv Res 2014; 2 (27): 49\u201377.","journal-title":"Health Serv Deliv Res"},{"key":"BFeye2015161_CR33","unstructured":"European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd edn. Editrice Dogma: Savona, Italy, 2008."},{"issue":"5","key":"BFeye2015161_CR34","doi-asserted-by":"publisher","first-page":"e002067","DOI":"10.1136\/bmjopen-2012-002067","volume":"3","author":"R Malik","year":"2013","unstructured":"Malik R, Baker H, Russell RA, Crabb DP . A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines. BMJ Open 2013; 3 (5): e002067.","journal-title":"BMJ Open"},{"issue":"1","key":"BFeye2015161_CR35","doi-asserted-by":"publisher","first-page":"e003996","DOI":"10.1136\/bmjopen-2013-003996","volume":"4","author":"FC Glen","year":"2014","unstructured":"Glen FC, Baker H, Crabb DP . A qualitative investigation into patients\u2019 views on visual field testing for glaucoma monitoring. BMJ Open 2014; 4 (1): e003996.","journal-title":"BMJ Open"},{"issue":"4","key":"BFeye2015161_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bjo.2007.135012","volume":"92","author":"BC Chauhan","year":"2008","unstructured":"Chauhan BC, Garway-Heath DF, Goni FJ, Rossetti L, Bengtsson B, Viswanathan AC et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 2008; 92 (4): 569\u2013573.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"BFeye2015161_CR37","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1167\/iovs.12-9476","volume":"53","author":"DP Crabb","year":"2012","unstructured":"Crabb DP, Garway-Heath DF . Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach. Invest Ophthalmol Vis Sci 2012; 53 (6): 2770\u20132776.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"BFeye2015161_CR38","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00417-007-0576-7","volume":"245","author":"NM Jansonius","year":"2007","unstructured":"Jansonius NM . Progression detection in glaucoma can be made more efficient by using a variable interval between successive visual field tests. Graefes Arch Clin Exp Ophthalmol 2007; 245 (11): 1647\u20131651.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"updated-by":[{"DOI":"10.1038\/eye.2015.186","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2015161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2015161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2015161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:25:29Z","timestamp":1684416329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2015161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFeye2015161"],"URL":"https:\/\/doi.org\/10.1038\/eye.2015.161","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/eye.2015.186","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]},"assertion":[{"value":"14 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2015","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}